What is HC Wainwright’s Forecast for Myomo FY2026 Earnings?

Myomo, Inc. (NYSEAMERICAN:MYO – Free Report) – Equities researchers at HC Wainwright increased their FY2026 EPS estimates for Myomo in a research report issued to clients and investors on Tuesday, November 10th. HC Wainwright analyst S. Lee now anticipates that the company will post earnings per share of ($0.31) for the year, up from their prior estimate of ($0.32). The consensus estimate for Myomo’s current full-year earnings is ($0.31) per share. HC Wainwright also issued estimates for Myomo’s Q4 2026 earnings at ($0.04) EPS, Q1 2027 earnings at ($0.04) EPS, Q2 2027 earnings at ($0.03) EPS, Q3 2027 earnings at ($0.03) EPS, Q4 2027 earnings at ($0.02) EPS, FY2027 earnings at ($0.12) EPS, FY2028 earnings at ($0.01) EPS, FY2029 earnings at $0.20 EPS and FY2030 earnings at $0.45 EPS.

Myomo Stock Performance

Shares of MYO opened at $1.23 on Thursday. The company has a current ratio of 1.92, a quick ratio of 2.01 and a debt-to-equity ratio of 4.24. The stock has a 50-day moving average price of $1.37 and a 200-day moving average price of $1.09. Myomo has a 12-month low of $0.60 and a 12-month high of $1.89.

Myomo (NYSEAMERICAN:MYO – Get Free Report) last issued its quarterly earnings data on Monday, November 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.01. Myomo had a negative return on equity of 183.47% and a negative net margin of 33.14%. The company had revenue of $12.33 million for the quarter, compared to the consensus estimate of $11.51 million.

Insiders Place Their Bets

In related news, insider Harry Kovelman sold 17,250 shares of the firm’s stock in a transaction that occurred on Thursday, August 20th. The shares were sold at an average price of $1.73, for a total value of $29,842.50. Following the sale, the insider directly owned 105,983 shares of the company’s stock, valued at $183,350.59. This trade represents a 14.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders have sold 47,738 shares of company stock valued at $70,662 over the last quarter. Company insiders own 12.14% of the company’s stock.

Hedge Funds Weigh In On Myomo

A hedge fund recently bought a new position in Myomo stock. Empowered Funds LLC purchased a new position in shares of Myomo, Inc. (NYSEAMERICAN:MYO – Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 39,619 shares of the company’s stock, valued at approximately $62,000. Empowered Funds LLC owned about 0.10% of Myomo as of its most recent SEC filing. 44.99% of the stock is currently owned by institutional investors and hedge funds.

More Myomo News

These are some of the MYO news items that stood out recently:

  • Positive Sentiment: Zacks upgraded Myomo to Rank #2 (Buy), citing improving earnings prospects—a change that may attract investor interest. Article: Myomo Upgraded to Buy
  • Positive Sentiment: HC Wainwright lifted its earnings estimates across multiple periods, including FY2027 to a loss of $0.12 per share from $0.28, and FY2028 to a loss of $0.01 from $0.18. It also raised FY2029 and FY2030 forecasts to earnings of $0.20 and $0.45 per share, respectively, suggesting a faster path toward profitability. Myomo analyst estimates

Myomo Company Profile

(Get Free Report)

Myomo, Inc. is a medical device company that develops and markets wearable robotic braces designed to help individuals with impaired upper-limb function regain movement and perform activities of daily living. Its principal product is the MyoPro, a lightweight, electrically powered orthosis that detects a user’s residual muscle signals and assists movement of the arm and hand. The MyoPro is intended for people affected by neuromuscular disorders and injuries, including stroke, brachial plexus injury, multiple sclerosis, traumatic brain injury and spinal cord injury.

Featured Stories

Earnings History and Estimates for Myomo (NYSEAMERICAN:MYO)

Receive News & Ratings for Myomo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Myomo and related companies with MarketBeat.com's FREE daily email newsletter.